We are live on ! Find out more
IART icon

Integra LifeSciences

278 hedge funds and large institutions have $4.71B invested in Integra LifeSciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 112 increasing their positions, 92 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $7.96M

22% more repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 92

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

0% more funds holding

Funds holding: 277278 (+1)

1.7% less ownership

Funds ownership: 91.4%89.7% (-1.7%)

9% less capital invested

Capital invested by funds: $5.16B → $4.71B (-$449M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
278
Holders Change
+1
Holders Change %
+0.36%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
112
Reduced
92
Closed
24
Calls
$10.2M
Puts
$7.96M
Net Calls
+$2.23M
Net Calls Change
+$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
HRCM
276
Hood River Capital Management
Florida
-$17.3M -258,975 Closed
RJFSA
277
Raymond James Financial Services Advisors
Florida
-$14.4M -215,001 Closed
MSE
278
MUFG Securities EMEA
United Kingdom
-$6.44M -96,100 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
279
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$5.82M -86,900 Closed
LIC
280
Laurus Investment Counsel
Canada
-$3.65M -42,593 Closed
CIC
281
Cornercap Investment Counsel
Georgia
-$1.02M -15,250 Closed
SM
282
Sciencast Management
New Jersey
-$969K -13,941 Closed
MLICM
283
Metropolitan Life Insurance Company (MetLife)
New York
-$872K -13,021 Closed
N
284
Natixis
France
-$603K -9,000 Closed
Pacer Advisors
285
Pacer Advisors
Pennsylvania
-$494K -7,381 Closed
Squarepoint
286
Squarepoint
New York
-$400K -5,976 Closed
FRM
287
Fox Run Management
Connecticut
-$373K -5,566 Closed
CCA
288
Conestoga Capital Advisors
Pennsylvania
-$335K -5,000 Closed
Marshall Wace
289
Marshall Wace
United Kingdom
-$272K -4,063 Closed
PAG
290
Private Advisor Group
New Jersey
-$268K -4,007 Closed
OTPPB
291
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$266K -3,972 Closed
ACM
292
Aubrey Capital Management
United Kingdom
-$228K -3,405 Closed
A
293
Astrantus
Cyprus
-$208K -3,100 Closed
FHA
294
First Horizon Advisors
Tennessee
-$79K -1,189 Closed
DFCM
295
Dark Forest Capital Management
Puerto Rico
-$14K -203 Closed
IPW
296
IronBridge Private Wealth
Texas
-$13K -191 Closed
CFO
297
CVA Family Office
Colorado
-$2K -30 Closed
EWA
298
EverSource Wealth Advisors
Alabama
-$1K -17 Closed
JFGIW
299
Johnson Financial Group Inc (Wisconsin)
Wisconsin
-$1K -12 Closed
AF
300
Allworth Financial
California
-$66 -1 -17%

IART Hedge Fund Activity: Q1 2022 in Review

278 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2022, worth a combined $4.71B — down 8.7% from $5.16B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IART positions and 24 closed out — a net gain of 5 holders — while 112 added to existing stakes and 92 trimmed.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $18.6M. The largest seller was Wellington Management Group, cutting an estimated $153M.

  • 278 institutional investors held Integra LifeSciences (IART) as of Q1 2022, up from 277 in Q4 2021.
  • Funds reported $4.71B of Integra LifeSciences stock for Q1 2022, down 8.7% quarter-over-quarter.
  • 29 funds opened new Integra LifeSciences positions in Q1 2022 and 24 closed out, a net change of +5 holders.
  • The largest Integra LifeSciences buyer in Q1 2022 was Two Sigma Investments, an estimated $18.6M added.
  • The largest Integra LifeSciences seller in Q1 2022 was Wellington Management Group, an estimated $153M sold.

Based on aggregated 13F filings for Q1 2022.